Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer (original) (raw)

• Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311–4320.
  Article CAS PubMed PubMed Central Google Scholar
• Hu L, McArthur C, Jaffe RB . Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 2010; 102: 1276–1283.
  Article CAS PubMed PubMed Central Google Scholar
• Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011; 71: 3991–4001.
  Article CAS PubMed PubMed Central Google Scholar
• Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009; 27: 2875–2883.
  CAS PubMed Google Scholar
• Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009; 28: 209–218.
  Article CAS PubMed Google Scholar
• O’Brien CA, Kreso A, Jamieson CH . Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16: 3113–3120.
  Article PubMed Google Scholar
• Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
  Article CAS PubMed Google Scholar
• Pasquier J, Rafii A . Role of the microenvironment in ovarian cancer stem cell maintenance. BioMed Res Int 2013; 2013: 630782.
  PubMed Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature 2008; 454: 436–444.
  Article CAS PubMed Google Scholar
• Yi L, Xiao H, Xu M, Ye X, Hu J, Li F et al. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J Neuroimmunol 2011; 232: 75–82.
  Article CAS PubMed Google Scholar
• Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8: R59.
  Article PubMed PubMed Central Google Scholar
• Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389–402.
  Article CAS PubMed Google Scholar
• Iliopoulos D, Hirsch HA, Struhl K . An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693–706.
  Article CAS PubMed PubMed Central Google Scholar
• Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010; 120: 485–497.
  Article CAS PubMed PubMed Central Google Scholar
• Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M et al. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J Natl Cancer Inst 2011; 103: 1884–1898.
  Article CAS PubMed Google Scholar
• Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P . CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150: 5445–5456.
  CAS PubMed Google Scholar
• Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, Kilpatrick L et al. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 2008; 10: R95.
  Article PubMed PubMed Central Google Scholar
• Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008; 57: 772–779.
  Article CAS PubMed Google Scholar
• Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn CJ, DeMarzo AM et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 2008; 14: 3254–3261.
  Article CAS PubMed PubMed Central Google Scholar
• Steiner GE, Newman ME, Paikl D, Stix U, Memaran-Dagda N, Lee C et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 2003; 56: 171–182.
  Article CAS PubMed Google Scholar
• Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF . Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 2008; 105: 15505–15510.
  Article CAS PubMed PubMed Central Google Scholar
• Kato T, Furumoto H, Ogura T, Onishi Y, Irahara M, Yamano S et al. Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 2001; 282: 735–738.
  Article CAS PubMed Google Scholar
• Murugaiyan G, Saha B . Protumor vs antitumor functions of IL-17. J Immunol 2009; 183: 4169–4175.
  Article CAS PubMed Google Scholar
• Shalom-Barak T, Quach J, Lotz M . Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998; 273: 27467–27473.
  Article CAS PubMed Google Scholar
• Subramaniam SV, Cooper RS, Adunyah SE . Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun 1999; 262: 14–19.
  Article CAS PubMed Google Scholar
• Subramaniam SV, Pearson LL, Adunyah SE . Interleukin-17 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937. Biochem Biophys Res Commun 1999; 259: 172–177.
  Article CAS PubMed Google Scholar
• Chang SH, Park H, Dong C . Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281: 35603–35607.
  Article CAS PubMed Google Scholar
• Shostak K, Chariot A . NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 2011; 13: 214.
  Article PubMed PubMed Central Google Scholar
• Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006; 15: 1894–1913.
  Article CAS PubMed Google Scholar
• Long H, Xie R, Xiang T, Zhao Z, Lin S, Liang Z et al. Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells 2012; 30: 2309–2319.
  Article CAS PubMed Google Scholar
• Kusumbe AP, Mali AM, Bapat SA . CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009; 27: 498–508.
  Article CAS PubMed Google Scholar
• Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175: 6177–6189.
  Article CAS PubMed Google Scholar
• Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468: 829–833.
  Article CAS PubMed Google Scholar
• Filatova A, Acker T, Garvalov BK . The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta 2013; 1830: 2496–2508.
  Article CAS PubMed Google Scholar
• Hamilton TC, Foster BJ, Grotzinger KR, McKoy W, Young RC, Ozols RF . Development of drug-sensitive and -resistant human ovarian cancer cell lines. Proc Am Assoc Cancer Res 1983; 24: 313.
  Google Scholar
• Ciucci A, De Stefano I, Vellone VG, Lisi L, Bottoni C, Scambia G et al. Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. PLoS One 2013; 8: e60145.
  Article CAS PubMed PubMed Central Google Scholar
• Domcke S, Sinha R, Levine DA, Sander C, Schultz N . Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 2013; 4: 2126.
  Article PubMed Google Scholar
• Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160: 3513–3521.
  CAS PubMed Google Scholar
• Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999; 162: 577–584.
  CAS PubMed Google Scholar
• Lai D, Wang F, Chen Y, Wang C, Liu S, Lu B et al. Human ovarian cancer stem-like cells can be efficiently killed by gammadelta T lymphocytes. Cancer Immunol Immunother 2012; 61: 979–989.
  Article CAS PubMed Google Scholar
• Lan C, Huang X, Lin S, Huang H, Cai Q, Lu J et al. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res 2013; 352: 351–359.
  Article CAS PubMed Google Scholar
• Takahashi H, Numasaki M, Lotze MT, Sasaki H . Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 2005; 98: 189–193.
  Article CAS PubMed Google Scholar
• Numasaki M, Lotze MT, Sasaki H . Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol Lett 2004; 93: 39–43.
  Article CAS PubMed Google Scholar
• Chen X, Xie Q, Cheng X, Diao X, Cheng Y, Liu J et al. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells. Cancer Sci 2010; 101: 2384–2390.
  Article CAS PubMed Google Scholar
• Du JW, Xu KY, Fang LY, Qi XL . Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer. Mol Med Rep 2012; 6: 1099–1102.
  Article CAS PubMed Google Scholar
• Kang Z, Wang C, Zepp J, Wu L, Sun K, Zhao J et al. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells. Nat Neurosci 2013; 16: 1401–1408.
  Article CAS PubMed PubMed Central Google Scholar
• Villalva C, Martin-Lanneree S, Cortes U, Dkhissi F, Wager M, Le Corf A et al. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int J Cancer 2011; 128: 826–838.
  Article CAS PubMed Google Scholar
• Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 2010; 463: 676–680.
  Article CAS PubMed Google Scholar
• Laine J, Kunstle G, Obata T, Sha M, Noguchi M . The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 2000; 6: 395–407.
  Article CAS PubMed Google Scholar
• Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009; 4: 226–235.
  Article CAS PubMed PubMed Central Google Scholar